Biacore International AB

As of August 15, 2006, Biacore International AB was acquired by GE Healthcare Limited. Biacore International AB provides systems that generate data on the interactions between proteins and small molecule drug candidates. The generated data is used in the areas of research, development, and manufacture to elucidate disease mechanisms and play a key role in the critical decisions needed for the development and production of therapeutics. It also offers food analysis solutions that provide manufacturers with a system and ready-to-use kits for the determination of food quality and safety. The company’s systems are used in the areas of antibody characterization, proteomics, lead characterization, immunogenicity, pharmaceutical drug discovery, immunogenicity, life science research, and bio-therapeutic development and production. It serves research centers, pharmaceutical companies, and biotechnology companies in the United States, Europe, Japan, and Australia. The company was founded in 1984 and is based in Uppsala, Sweden.